Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    23828223 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Study of HQK-1001 in Patients With Sickle Cell Disease
Conditions: Sickle Cell Disease;   Sickle Cell Anemia;   Sickle Cell Disorders;   Hemoglobin S Disease;   Sickling Disorder Due to Hemoglobin S
Intervention: Drug: HQK-1001
2 Completed Gum Arabic as Fetal Hemoglobin Agent in Sickle Cell Anemia
Condition: Sickle Cell Anemia
Intervention: Dietary Supplement: Gum Arabic

Study has passed its completion date and status has not been verified in more than two years.